A total of 45 healthy volunteers aged 18 to 55 years will take part in the trials. It is reported by the Associated Press, citing its own sources.
Read also In the US, police asked not to commit crimes during the coronavirus pandemic
Volunteers will receive different doses of the vaccine developed by Moderna, a biotechnology company based in Massachusetts, as well as the US National Institutes of Health,
– the message says.
The tests will be conducted at a research institute in Seattle.
Volunteers cannot become infected with coronavirus, because vaccine samples do not contain the virus. The purpose of the test is to ensure that vaccines do not have serious side effects. Then it will be possible to proceed to the stage of large-scale tests.
Inovio Pharmaceuticals also plans to launch trials of its vaccine soon. They will be held at the University of Pennsylvania and the Kansas City Test Center. Dozens of volunteers will take part in the tests.
In the field of healthcare, the United States notes that the full introduction of a potential vaccine needs from 12 to 18 months.
The main thing about coronavirus in the world
As of March 16, 6 thousand 518 people died from viral pneumonia, which was provoked by coronavirus. The total number of infected – 169 thousand 719 people around the world. There is good news – almost 78 thousand people recovered. On March 13 in Ukraine, the first person died from a coronavirus – a woman from Radomyshl. In addition, there are two more confirmed cases of the disease. After China, Italy has the highest coronavirus infection rate. The country recorded 1 thousand 809 deaths. In China itself, the incidence rate has declined. There is still no 2019-nCoV coronavirus vaccine. In addition to the United States, work on its development in China.
Simple rules that can save a life / Infographics 24 channels